Replies to post #521319 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Neon tried polypeptide. Argos tried MRNA.

[supersteve13]

how did you arrive at that estimate?

[Know-Fear]

So you’re advocating for production of 17,179,869,183 variants of the vaccine in order to achieve personalized? Or for sanity sake in production do you think they’ll minimize it down to a manageable amount of variants? Which hopefully achieve efficacy with a manageable toolbox of vaccines.

[biosectinvestor]

That’s not personalized. And no, they likely won’t make it personalized, that is not the point of mRNA, it is to make more vaccines quickly, but it is still engineered and artificial, off the shelf and not personalized.

Melanoma is the target specifically because it is an easy cancer and has a very limited antigen requirement. As I just said in a previous post, there are already very good treatments for melanoma now, but another one will be great. But it’ a great target for them because it has really no need for personalization at all.